UHS:NYE-Universal Health Services Inc. (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 178.91

Change

+0.32 (+0.18)%

Market Cap

USD 11.70B

Volume

1.01M

Analyst Target

USD 129.60
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Universal Health Services Inc through its subsidiaries is engaged in the business of owning and operating acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-14 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

N/A

USD 88.24B
THC Tenet Healthcare Corporation

N/A

USD 13.21B
DVA DaVita HealthCare Partners Inc

N/A

USD 12.90B
FMS Fresenius Medical Care Corpora..

N/A

USD 12.48B
EHC Encompass Health Corp

N/A

USD 8.51B
CHE Chemed Corp

N/A

USD 8.36B
SEM Select Medical Holdings

N/A

USD 4.49B
AGL agilon health Inc

N/A

USD 2.80B
AMN AMN Healthcare Services Inc

N/A

USD 2.06B
NHC National HealthCare Corporatio..

N/A

USD 1.58B

ETFs Containing UHS

UTRN Vesper U.S. Large Cap Sho.. 4.14 % 0.00 %

N/A

USD 0.02B
XLVE:CA Mulvihill U.S. Health Car.. 1.71 % 0.00 %

N/A

CAD 7.13M
RNMC First Trust Mid Cap US Eq.. 1.11 % 0.60 %

N/A

USD 0.02B
ZUH:CA BMO Equal Weight US Healt.. 0.00 % 0.39 %

N/A

CAD 0.29B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.36% 52% F 88% B+
Dividend Return 0.13% 25% F 5% F
Total Return 17.50% 52% F 88% B+
Trailing 12 Months  
Capital Gain 33.11% 70% C- 81% B-
Dividend Return 0.60% 22% F 5% F
Total Return 33.70% 70% C- 80% B-
Trailing 5 Years  
Capital Gain 47.01% 69% C- 69% C-
Dividend Return 2.71% 29% F 8% B-
Total Return 49.72% 63% D 64% D
Average Annual (5 Year Horizon)  
Capital Gain 5.85% 55% F 60% D-
Dividend Return 6.35% 55% F 54% F
Total Return 0.50% 25% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 27.15% 77% C+ 41% F
Risk Adjusted Return 23.39% 59% D- 45% F
Market Capitalization 11.70B 83% B 85% B

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 17.30 65% 58%
Price/Book Ratio 1.83 64% 45%
Price / Cash Flow Ratio 8.95 38% 42%
Price/Free Cash Flow Ratio 9.63 46% 44%
Management Effectiveness  
Return on Equity 13.31% 64% 69%
Return on Invested Capital 8.76% 63% 61%
Return on Assets 5.82% 79% 77%
Debt to Equity Ratio 77.83% 52% 46%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector